blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1695701

EP1695701 - HFA suspension formulations comprising an anticholinergic agent [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.11.2015
Database last updated on 19.10.2024
Most recent event   Tooltip13.10.2017Lapse of the patent in a contracting state
New state(s): BE, CY, HU, PT, TR		published on 15.11.2017  [2017/46]
Applicant(s)For all designated states
Boehringer Ingelheim Pharma GmbH & Co. KG
A Patente
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2015/02]
Former [2014/37]For all designated states
Boehringer Ingelheim Pharma GmbH & Co. KG
A Patente
Binger Strasse 173
55216 Ingelheim am Rhein / DE
Former [2006/35]For all designated states
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim am Rhein / DE
Inventor(s)01 / Schmelzer, Dr., Christel
Welfenstrasse 14
55218 Ingelheim / DE
 [2014/37]
Former [2006/35]01 / Schmelzer, Dr., Christel
Welfenstrasse 14
55218, Ingelheim / DE
Representative(s)Eckhardt, Conrad, et al
Boehringer Ingelheim GmbH CD Patents Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2015/02]
Former [2008/17]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Former [2006/35]Hammann, Heinz
Boehringer Ingelheim GmbH CD Patents Binger Strasse 173
D-55216 Ingelheim Am Rhein / DE
Application number, filing date06115508.120.03.2003
[2006/35]
Priority number, dateDE200211426328.03.2002         Original published format: DE 10214263
[2006/35]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report 
No.:EP1695701
Date:30.08.2006
Language:DE
[2006/35]
Type: A3 Search report 
No.:EP1695701
Date:28.04.2010
[2010/17]
Type: B1 Patent specification 
No.:EP1695701
Date:07.01.2015
Language:DE
[2015/02]
Search report(s)(Supplementary) European search report - dispatched on:EP31.03.2010
ClassificationIPC:A61K9/72, A61K31/46, A61P11/06
[2006/35]
CPC:
A61K9/008 (EP); A61K9/10 (KR); A61K31/439 (EP);
A61K9/00 (KR); A61K9/12 (KR); A61P11/00 (EP);
A61P11/06 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2006/35]
TitleGerman:HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum[2006/35]
English:HFA suspension formulations comprising an anticholinergic agent[2006/35]
French:Formulations de suspension contenant un gaz propulseur HFA et un anticholinergique[2006/35]
Examination procedure12.05.2010Amendment by applicant (claims and/or description)
31.05.2010Examination requested  [2010/28]
06.10.2010Despatch of a communication from the examining division (Time limit: M06)
18.04.2011Reply to a communication from the examining division
14.08.2014Communication of intention to grant the patent
26.11.2014Fee for grant paid
26.11.2014Fee for publishing/printing paid
26.11.2014Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP03745193.7  / EP1492513
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030745193) is  21.06.2005
Opposition(s)08.10.2015No opposition filed within time limit [2015/51]
Fees paidRenewal fee
14.12.2006Renewal fee patent year 03
14.12.2006Renewal fee patent year 04
02.04.2007Renewal fee patent year 05
31.03.2008Renewal fee patent year 06
31.03.2009Renewal fee patent year 07
31.03.2010Renewal fee patent year 08
31.03.2011Renewal fee patent year 09
31.03.2012Renewal fee patent year 10
02.04.2013Renewal fee patent year 11
31.03.2014Renewal fee patent year 12
Penalty fee
Additional fee for renewal fee
14.06.200603   M06   Fee paid on   14.12.2006
14.06.200604   M06   Fee paid on   14.12.2006
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU20.03.2003
CY07.01.2015
CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
IT07.01.2015
MC07.01.2015
NL07.01.2015
RO07.01.2015
SE07.01.2015
SI07.01.2015
SK07.01.2015
TR07.01.2015
AT20.03.2015
IE20.03.2015
LU20.03.2015
BE31.03.2015
CH31.03.2015
LI31.03.2015
BG07.04.2015
GR08.04.2015
PT07.05.2015
[2017/40]
Former [2016/36]CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
IT07.01.2015
MC07.01.2015
NL07.01.2015
RO07.01.2015
SE07.01.2015
SI07.01.2015
SK07.01.2015
AT20.03.2015
IE20.03.2015
LU20.03.2015
CH31.03.2015
LI31.03.2015
BG07.04.2015
GR08.04.2015
Former [2016/12]CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
IT07.01.2015
MC07.01.2015
NL07.01.2015
RO07.01.2015
SE07.01.2015
SI07.01.2015
SK07.01.2015
IE20.03.2015
LU20.03.2015
CH31.03.2015
LI31.03.2015
BG07.04.2015
GR08.04.2015
Former [2016/07]CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
IT07.01.2015
MC07.01.2015
NL07.01.2015
RO07.01.2015
SE07.01.2015
SK07.01.2015
IE20.03.2015
LU20.03.2015
CH31.03.2015
LI31.03.2015
BG07.04.2015
GR08.04.2015
Former [2016/06]CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
IT07.01.2015
MC07.01.2015
NL07.01.2015
RO07.01.2015
SE07.01.2015
SK07.01.2015
LU20.03.2015
CH31.03.2015
LI31.03.2015
BG07.04.2015
GR08.04.2015
Former [2016/03]CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
IT07.01.2015
MC07.01.2015
NL07.01.2015
RO07.01.2015
SE07.01.2015
SK07.01.2015
LU20.03.2015
BG07.04.2015
GR08.04.2015
Former [2015/49]CZ07.01.2015
DK07.01.2015
EE07.01.2015
ES07.01.2015
FI07.01.2015
MC07.01.2015
NL07.01.2015
RO07.01.2015
SE07.01.2015
SK07.01.2015
LU20.03.2015
BG07.04.2015
GR08.04.2015
Former [2015/47]ES07.01.2015
FI07.01.2015
MC07.01.2015
NL07.01.2015
SE07.01.2015
LU20.03.2015
BG07.04.2015
GR08.04.2015
Former [2015/46]ES07.01.2015
FI07.01.2015
MC07.01.2015
NL07.01.2015
SE07.01.2015
BG07.04.2015
GR08.04.2015
Former [2015/39]ES07.01.2015
FI07.01.2015
NL07.01.2015
SE07.01.2015
BG07.04.2015
GR08.04.2015
Former [2015/37]ES07.01.2015
FI07.01.2015
SE07.01.2015
BG07.04.2015
GR08.04.2015
Former [2015/36]ES07.01.2015
FI07.01.2015
SE07.01.2015
BG07.04.2015
Former [2015/33]ES07.01.2015
Documents cited:Search[A]WO0007567  (JAGO RES AG [CH], et al) [A] 1-9 * example 7 *;
 [A]WO0178743  (GLAXO GROUP LTD [GB], et al) [A] 1-9* examples 1-3 *;
 [AP]WO0230928  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [AP] 1-9 * page 10, line 33 - page 11, line 9 * * claim 1 *;
 [XP]WO0236106  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [XP] 1-6,8-9 * page 17, line 11 - line 39 * * page 19 * * claims 22,35 *;
 [XP]WO0238154  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [XP] 1-6,8-9 * page 16, line 23 - page 17, line 11 * * page 18, line 5 - paragraph L *
ExaminationWO0069468
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.